Role of Medical Representative – PPT PDF – Interview Special

Primary roles & responsibilities of Medical Representative include:

Primary roles & responsibilities of Medical Representative include:

Primary roles & responsibilities of Medical Representative include:

  1. Organising appointments and meetings with Doctors
  2. Writing reports and other documents regarding the assigned Formulations
  3. Identifying and establishing new business leads
  4. Getting feedback on the product and Marketing the Feedback
  5. Company Representation
  6. Introducing the product in the market
  7. Promotion of Pharma products
  8. Achieving sales target
  9. Organizing conferences and meetings
  10. Reviewing sales performance during week and month
  11. Negotiating contracts
  12. demonstrating or presenting products to healthcare staff including doctors, nurses and pharmacists
  13. Attending  trade exhibitions, conferences and meetings
  14. managing budgets
  15. Perfect knowledge on
  16. Patient Population
    » Provider of healthcare services
    » Prescriber of medicines/ treatment
    » Product provider/ seller
    » Payer

 

What are Key Skills of a Professional Medical Representative:

  1. Perfect sales men
  2. Proficient in Microsoft Word, Excel, Outlook, and PowerPoint.
  3. Excellent communication skills
  4. Dedicated and target-oriented.
  5. Disciplined and punctual.
  6. hard working.
  7. Precise Decision making skills
  8. Self-motivated.
  9. Great presentation skills
  10. Deep product knowledge
  11. Ability to work under pressure
  12. Strong Medical Knowledge

 

What are the organization expectations from the doctors through Medical Representative Work

  • x To generate and increase good numbers of prescription.
  • x To generate and increase good numbers of prescriber base.
  • x Brand establishment.
  • x Satisfying customers need and developing Loyal Customers.
  • x Growth in sales.
  • x To establish the company as well as product image at market place.
  • x Profitability and
  • x Service to human welfare.

What are the expectations from the Pharma companies by doctors? Every Medical representative must know

Scientific Information and Educations
Quality products
Solution to their Patients problems
Patients’ benefits
Regular visits by Medical representatives and senior managers
Satisfying their needs or Sponsorship

Pharmaceutical Promotional Methods:

The promotional methods in pharmaceutical marketing includes personal selling, advertising, sales promotion and publicity. These can be further segmented for the purpose of better understanding,
(i) Personal Selling: Medical sales representative or Medical representatives detail the company’s product to doctors, with the help of visual aids, leave- behind-literature, product monographs, samples, gifts, etc. which are the most important elements of pharmaceuticals promotion.
(ii) Advertising: Preparation of visual aids, leave-behind-literature, product monographs to assist medical sales representatives in their detailing efforts, and advertising their products in specialized media like medical journals and souvenirs, seminars and medical symposia and mailers for doctor.
(iii) Sales Promotion: Deciding on special bonus offers, free samples, gifts and sponsorship.
(iv) Publicity: Organizing medical symposia and seminars, conducting clinical trials, conducting exhibitions, designing and executing product publicity campaigns for truly innovative products.

Pharmaceutical Jurisprudence GPAT RRB Questions & Answers {PDF}

Pharmaceutical Jurisprudence GPAT Questions & Answers {PDF}

Pharmaceutical Jurisprudence GPAT Questions & Answers {PDF} which is really helpful for RRB railway recruitment board pharmacist examination.

 

Pharmaceutical jurisprudence Questions

Medicinal and Toilet preparations (Excise duties) Act 1955

1969
1955
1958
1948

Which indication must be prescribed on the label of ophthalmic ointments
A. Use within 1 month of opening
B. It is dangerous to take this preparation except under medical supervision
C. Consult to Physician if irritation persist, discontinue the use
D. Not for human use

Narcotic Drug and Psychotropic substances Act 1985
1955
1965
1975
1985

Which one of these is not CONSUMER DISPUTE REDRESSAL AGENCIES
1) A Consumer Dispute Redressal Forum at the District level.
2) A Consumer Dispute Redressal Commission at the State level.
3) A National Consumer Dispute Redressal Commission at national level.
4) A Consumer Dispute Redressal Commission at the constitution level.

First Edition of Indian Pharmacopoeia was published in 1955

1951
1955
1960
1970

The State Pharmacy Council consist s of the following except

the chief administrative medical officer
the Government Analyst.
Six members, elected from amongst themselves by registered pharmacists
Registered nurse

Which Schedule of the Drugs and Cosmetics Act governs the clinical trials legislative requirements of the Drugs and Cosmetics
Act.

Schedule X
Schedule Y
Schedule M
Schedule C

“New Drugs” shall mean and include all Except

Drugs not previously available in Indian market
Drugs with new therapeutic indications or dosages that have not been marketed in India.
New fixed -dose combinations of two or more drugs.
Any drug which was already approved in India and included in the Indian pharmacopoeia.

multiple choice questions with answers on jurisprudence PDF

Medical stores are inspected by drug inspector for at least
A. Once a year
B. Twice in a year
C. Thrice in a year
D. Quarterly in a year

 

WHO IS NOT A CONSUMER ?
A. Legal heir of consumer in case death of consumer
B. Any person who buys goods for resale or commercial purpose and services for commercial purpose
C. However any person who buys goods for commercial use but exclusively for his livelihood by means of self employment is a consumer

D. Any person who buys goods or avails services for consideration

 

Pharmaceutical Jurisprudence GPAT Multiple Choice Questions & Answers {PDF}pdf

Pharmacy Near ME – Bangalore 24/7 Free Online Home Delivery – Contact

Pharmacy Near ME - Bangalore 24/7 Free Online Home Delivery - Contact

List of 24/7 Pharmacies in Bangalore with shop pharmacy Name  Address Mobile Phone

  • Apollo Pharmacy (A Unit of Apollo Hospitals Enterprises ltd)
    No.06, Ground floor, Railway
    bridge road,Kumara park
    East,560001
    9900054615 Bangalore Circle
  •  SUGUNA NARAYANA HEART CENTRE( UNIT OF NH PRIVATE LIMITED)
    No.1A/87, Dr.Rajkumar Road,
    SUGUNA HOSPITAL -2
    FLOOR,4th N Block,
    Rajajinagar,560010
    9538066577 Bangalore Circle
  • function of hospital pharmacy
  • GREEN APPLE ( A UNIT OF RADIANT HEALTH CARE PVT. LTD.)
    # 2 VITTAL MALYA ROAD, ( In
    patient )BANGALORE560001
    9342497305 Bangalore Circle
  • CYTESPACE RESEARCH PVT.LTD
    K.NO.9/3, NITESH
    BROADWAY, GF, MG
    ROAD,MG ROAD560001
    9986243891 Bangalore Circle
  • SAI HOSPI ESSENTIALS
    #117,DODDABETTAHALLI,
    GFVIDYARANYAPURA
    POST560097
    720436696 Bangalore Circle
  • ALARIC ENTERPRISES # 11/1, 4TH FLOOR, 8TH
    CROSS,MALLESHWARAM560
    003
    8095033311 Bangalore Circle
  •  MANJUSHREE MEDICALS
    SHOP NO.01, NO.13, 7TH
    MAIN, BHUVANESHWARI
    NAGAR,HESARAGHATTA
    MAIN ROAD,560057
    9611297373 Bangalore Circle
  • COLUMBIA ASIA REFERRAL HOSPITAL
    (PHARMACY)
    # 26/1, SUBRAMANYANAGAR
    INDUSTRIAL
    SUBURB,MALLESWARAM
    WEST560055
    9448051876 Bangalore Circle
  • People Tree Pharma (Unit of TMI Healthcare Pvt.Ltd)
    No.2, Service Road, Opp.Taj
    Vivanta, Tumkur Road,NH-4,
    Gorguntepalya,
    yeshwanthpur,560022
    9886058284 Bangalore Circle
  • AVEKSHA MEDICALS (AVEKSHA HOSPITAL PREMISES)
    NO.647/4,5,6/102/103/121/122A
    , GF, VARADARAJASWAMY
    LAYOUT,SINGAPURA
    VILLAGE, M.S.PALYA,
    VIDYARANAYAPURA
    POST,560097
    9886553086 Bangalore Circle
  • MANIPAL NORTHSIDE HOS,O.P. PHARMA(A UNIT OF MANIPAL HEALTH
    NO.5/2, 8TH MAIN ROAD,
    13TH CROSS,
    GF,MALLESHWARAM560003
    9740311505 Bangalore Circle
  • FAMILY PHARMA ( A
    UNIT OF FAMILY
    HEALTH PROVIDERS
    PVT, LTD.)
    NO.423/2, NEW NO.11/1, 60ft,
    Rd,1st MAIN 1st STAGE,
    GOKULAMATHIKERE MAIN
    ROAD, MATHIKERE560054
    9448189988 Bangalore Circle
  • PALS HEALTHCARE #15, Shop No.02, 1st Floor,
    Aditya Nagar,1st stage,
    Chickkabettahalli,
    Vidyaranyapura(P)560097
    8904087542 Bangalore Circle
  • FRANK ROSS PHARMA
    (A DIVISION OF EMAMI
    FRANK ROSS LTD)
    NO.53,GF,RATAN MAHAL
    LODGE COMPLEX,4 th
    CROSSSAMPIGE
    ROAD,MALLESHWARAM560003
    9535056899 Bangalore Circle
  • Religare Wellness
    (Religare Welness ltd)
    Old No;37, New No;36, Castle
    street,Ashok Nagar,560025
    9663368681 9663368681 Bangalore Circle
  • JENUSHREE MEDICALS & GENERAL STORES
    NO-115/1, GROUND FLOOR,
    6TH CROSS, BAPUJI
    LAYOUT,Opp. CHANDRA
    LAYOUT CANARA
    BANK,560040
    9448949830 Bangalore Circle
    4-
    43329 CHAYA PHARMA NO.6, (GROUND FLOOR), 5TH
    MAIN,O.M.B.R. LAYOUT,
    B.CHANNASANDRA ,560043
    9880847339 Bangalore Circle
  •  PLASMAGEN BIOSCIENCES PVT.
    LTD.
    #1342, ground floor, Dr.
    Shivaramkaranth
    Nagar,M.C.E.H.S Lay out,
    Yelahanka Hobli560064
    9731557200 Bangalore Circle
  • SHREE RANGANATHA
    MEDICALS
    #493,GF,17TH
    CROSS,JAKKUR
    LAYOUT560064
    9611261394 Bangalore Circle
  • CHAITANYA PHARMA NO.971/24, K.H.B.COLONY, A
    SECTOR,YELAHANKA NEW
    TOWN,560064
    9845625363 Bangalore Circle
  • APPLE PHARMA APPLE HOSPITAL, PLOT NO.
    17/B-18, 19, 20 C
    SECTOR,YELAHANKA NEW
    TOWN, YELAHANKA,
    DODDABALLAPURA MAIN
    ROAD,560064
    9945690149 Bangalore Circle
  • M/S PRUNUS
    LIFESCIENCES INDIA
    PVT LTD
    NO. 7, SRI MATHA, RAJA
    RAJESHWARI
    BLOCK,HEBBAL,560024
    9482510759 Bangalore Circle
    5-
    38024 Sure Fertilityy (India) Pvt
    Ltd
    No 115,Kodihalli,Old Airport
    road560017
    9900533338 Bangalore Circle
  • St. Johns Medical
    Collage Hospital Pharma
    St. Johns Medical Collage
    Hospital CampusSarjapura
    Road560034
    9999999999 Bangalore Circle
  • St.JohnS Medical
    College Hospital Pharma
    (2nd Floor)
    No-67-3-141/2, 2nd Floor
    St.JohnS Medical College
    HospitalPremises Sarjapur
    Road560034
    8022065000 Bangalore Circle
  • St.JohnS Medical
    College Hospital Pharma
    (3rd Floor)
    No-67-3-141/2, 3rd Floor
    St.JohnS Medical College
    HospitalPremises Sarjapura
    Road560034
    8022065000 Bangalore Circle
  • St.JohnS Medical
    College Hospital Pharma
    (4rd Floor)
    No-67-3-141/2, 4th Floor,
    St.JohnS Medical College
    HospitalPremises Sarjapura
    Road560034
    9036178807 Bangalore Circle
  •  Munipal Hosptal ICU
    Pharma
    No.133, (old No. 98), 3rd Floor,
    Manipal HospitalRustom Bagh,
    Old Airport Road,560017
    9844582343 Bangalore Circle
  • S&S Pharma Sy. No-29 M/s.Shiva & Shiva
    Orthopadic Hospital
    PrimesesKitegenahalli
    Village560099
    9242820155 Bangalore Circle

Free Home Delivery Pharmacies in Bangalore

  • 24688 Hrudayalaya Pharma &
    General Stores
    No-258/A, Narayana
    HrudayalaBommasandra Ind
    Area, Anekal Taluk,560099
    9900193614 Bangalore Circle
  • 29912 Trust Chemists &
    Druggist Ltd.
    No-86, Hosur
    RoadMadiwala560068
    9902973291 Bangalore Circle
  • 10165 Vijayashree Medicals No-03, G Floor, Bannerghatta
    Main RoadGottigere560083
    9945671947 9980512867 Bangalore Circle
  • 34759 Spring Leaf Healthcare
    Pvt Ltd.
    No-60/3, G Floor, Electronic City
    Next to Andra BankHosur Main
    Road560100
    8867346685 08067345000 Bangalore Circle
  • 42709 THE OXFORD DRUG
    STORES (CHILDERN
    EDUCATION SOCIETY)
    The Oxford Medical Hospital
    and Research Centre,S.No 20,.
    Yedavanahalli, Attibele Hobli,
    Anekal (TQ),562107
    9845037176 Bangalore Circle
  • 44289 SHAKTI MEDICAL AND
    GENERAL STORES
    NO. 9-10-172, SHOP NO.2,
    GROUND
    FLOOR,KUMBARWADA ROAD,
    9448125855 Bidar Circle
    43223 SRI OM SAI MEDICAL
    AND GENERAL STORE
    SHOP NO:1 BUILDING
    NO:1005/1OPP BASAVA HIGH
    AND PRIMARY
    SCHOOL,MANAHALLI
    9448572203 Bidar Circle
    43322 RATNADEEP
    MEDICALS (
    PHARMACEUTICAL
    DISTRIBUTORS )
    CMC NO:12-1-34 & 12-1-37,
    ROOM NO. 1,2 & 3, GROUND
    FLOORNAZARATH COLONY
    ,BEHIND KARNATAKA
    COLLEGE585401
    8861055999 Bidar Circle
    23303 BASAVA MEDICAL
    AND GENERAL
    STORES
    19-91/18,MAIN RAOD 9945511891 Bidar Circle
    28350 NEW BHARATHI
    MEDICAL & GENERAL
    STORES
    DOOR NO: 117/2/1, WARD NO:
    17, GROUND FLOORSHOP
    NO: 1, MAYURA HOTEL
    COMPLEX, DOUBLE
    ROAD583101
    9448234437 9738598776 Bellary Circle
  • 21874 SWETHA MEDICAL &
    GENERAL STORES
    DOOR NO: 81,Opp to GOVT
    PRIMARY SCHOLL,583115
    9448941511 Bellary Circle
  • 11782 BELLARY MEDICALS
    AND GENERALS ( 24
    HOURS )
    STALL NO: 5, WARD
    NO:17,EDIGA HOSTEL
    COMPLEX, COURT
    ROAD,583101
    968600838 Bellary Circle
  • 36341 K.L.E. Pharma Gokak CTS.No.3777/A-1,Main
    Road,591307
    9448420863 08332229977 Belgaum Circle
    34478 B. H. C. S. Pvt. Ltd,
    Lake View Medical
    Stores
    B.H.S. Lakeview Hospital
    Premises,RS. No.73/7, CTS.
    No.11888, Opp. Fort
    Lake590016
    8747945929 Belgaum Circle
  • 20235 THE MEDICAL
    SUPERINTENDENT OF
    BLDEA CENTRAL
    DRUGS STORES,
    SHR.B. M. PATIL HOSPITAL
    AND RESEARCH CENTRE,
    CTS NO. 30-6,WARD NO. 1,
    GROUND FLOOR, ASHRAM
    ROAD,586101
    9448245534 Bijapur Circle
    16123 M.V.J.Medical College &
    Research Centers
    Pharmacy
    K.No: 149, 152/1 &
    150,Dandupalya562114
    8453304403 Bangalore Circle
    Rural
    41182 Sri Basaweshwara
    Medicals , (Unit of
    Basaweshwara medical
    college Hospital &
    Research Center)
    Katha No. 6891/C , 5th Block
    A.No.14386/C Paediatric
    BlockBasaweshwara medical
    college Hospital Premises NH4
    Bye Pass577501
    9008861111 Chitradurga
    Circle
    44645 Ekadantha Associates 1st Block ,B.M.
    ROAD,BYCHANAHALLI571234
    9845381040 Kodagu Circle
    45975 LIFE LINE HOSPITAL, NO 271,24/18,PONNAMPET
    ROAD,571213
    9448720175 Kodagu Circle
    31992 PRASHANTH PHARMA. DOF-105,KONDANGERI. 9480256291 Kodagu Circle
    22578 CAUVERY MEDICALS NO:5TMC COMPLEX, G T
    ROAD,
    9448887570 Kodagu Circle
    22580 VINOD MEDICALS SHOP NO:4, BLOCK NO:20,
    MUDDU COMPLEX,CHIKPET,
    9845353439 Kodagu Circle
    29241 SRI GANESH
    MEDICALS,
    NO: 29/11A,
    ADHARACOLLEGE
    ROAD,571201
    9448976839 08272229662 Kodagu Circle
    29239 KANARA STORES # 6-7-1,CHOWKI,571201 9916808136 08272229314 Kodagu Circle
    22576 SURAKSHA MEDICALS SHOP NO:1,MAIN ROAD, 9448011434 Kodagu Circle
    24732 JANATHA BAJAR
    MEDICALS,
    SURVEY NO:88/3, SHOP NO:
    1,GOVT BUS STAND, B.M.
    ROAD,
    9448278168 08276274496 Kodagu Circle
    24857 ASHWINI MEDICALS, SMPT 92/8, 1ST BLOCKB.M.
    ROAD,
    9448720102 08272662322 Kodagu Circle
    34277 RAMA MEDICALS # 66/1,MYSORE MANGALORE
    ROAD,571237
    9448582053 08276262412 Kodagu Circle
    31952 SRI GANESH
    MEDICALS,
    HOUSE NO: 16A, R.NO:
    124/B,SIDDAPURA ROAD,
    9448448763 0827446655 Kodagu Circle
    32368 VAISHNAVI MEDICALS BAPU COMPLEX,NEAR BUS
    STAND,
    9880877187 08274249624 Kodagu Circle
    32397 ATHREYA DRUG
    HOUSE,
    NO:15,16 AND 16/2,BLOCK
    NO:10, S. S. RAMA MOORTHY
    ROAD,
    9999999999 08274257483 Kodagu Circle
    31130 MAHAVEER MEDICALS MAIN ROAD,VIRAJPET571218 9008509929 Kodagu Circle
    30947 SRI RAMA MEDICALS, SURVEY NO:37/10, SHOP
    NO:4/46,4TH BLOCK, NANDI
    COMPLEX, KUDIGE
    ROAD,571234
    9448504328 08276320080 Kodagu Circle
    31089 BHAGAVATHI
    MEDICALS,
    NO:521, SURVEY NO:
    35/1,5TH BLOCK, NEAR
    GANAPATHI TEMPLE, MAIN
    ROAD,
    9448217187 08276260205 Kodagu Circle
    31112 BHAGYALAKSHMI
    MEDICALS.
    DOOR NO:49, MUNICIPALITY
    BUILDING,NEAR PRIVATE
    BUS STAND,
    9845537456 08274256457 Kodagu Circle
    31976 AMBIKA MEDICALS, NO:1-135,MAIN ROAD, 9449253701 Kodagu Circle
    31800 SHIFA MEDICALS, SHOP NO: 1, BLOCK NO:1-
    58,BASEMENT FLOOR
    DADUTHI CHOWK, FMC
    ROAD,
    9241986262 9880927707 Kodagu Circle
    38670 GOUTHAM MEDICALS SHOP NO:8, MUDDU
    COMPLEX,G. T. ROAD,
    9448368397 Kodagu Circle
    40336 M.S.COORG
    MEDICALS
    BLDG # 81/5, BLOCK # 5,
    BASEMENT, CORNER
    SHOPINDIRAGANDHI CIRCLE,
    CHOWK571201
    9483615791 Kodagu Circle
    40423 VAATSALYA
    MEDICALS A UNIT OF
    VAATSALYA H.C.S
    PVT LTD.,
    Ass No: 13548/8702, JOLDAL
    HEALTHCARE
    COMPLEX,RATNA GIRI
    ROAD,577101
    9448899572 Chickmagalore
    Circle
    35080 VAATSALYA MEDICAL
    (Unit of Vaatsalya H.C.S
    Pvt. Ltd)
    A. No: 4781/4632A, Room No:
    6,Vaatsalya Hospital Ashirvad
    Health Care Complex , B.H.
    Road577228
    9611948124 Chickmagalore
    Circle
    44688 SREE LAKSHMI
    MEDICARE
    ASS NO: 5858/4185BELT
    ROAD, AMBEDKAR
    CIRCLE577101
    9481157430 Chickmagalore
    Circle
    39244 M/s, Sri Amogha
    Enterprises,
    01, Kathe No C20/15,Sampige
    Road,571313
    9980562848 Chamarajanagar
    Circle
    41549 SRI VIGNESHWARA
    DISTRIBUTERS
    #2069/12, 1st Floor, Davalagi
    Building2nd Main, 2nd Cross,
    MCC A Block
    9844690777 Davanagere
    Circle-
    19269 Basaveshwara Drugs &
    Ssurgical -UNIT II
    Building No. 1-11, G. F. HKES
    Society,Basaveshwara Teaching
    And General Hospital
    PRE585105
    8886858578 Gulbarga Circle
    25049 Vaatsalya Life Hospital
    Medical Store
    Site No: 178/19 to 178/23,
    SY.No. 117/1-4, inside
    VaatsalyaHospital, Ground
    Floor, Badepur RTO Cross,
    Sedam Road,585105
    9742725786 Gulbarga Circle
    46070 SDM PHARMA-IV BUILDING NO.114/3 TO 120/1,
    GR. FLOOR,SDM COLLEGE
    OF MEDICALSCIENCES &
    HOSPITAL, SUPER
    SPECIALITY HOSPITAL
    BLOCK,580009
    9742267797 Dharwad Circle
    25925 SRI
    CHANNAVEERESHWA
    R MEDICAL AND
    GENERAL STORES.
    VPC NO.75K,BASAVESHWAR
    TEMPLE ONI,
    9886864120 294232 Dharwad Circle
    18343 Kavyashree Medicals K.No:1483/1239,Chikkamagalur
    u Road, Nehru nagar573115
    9620335060 Hassan Circle
    46281 VEERAPUR MEDICALS CTS NO. 28 D, PLOT NO.2,
    GROUND FLOOR,NEXT TO
    VEERAPUR MULTI
    SPECIALITY
    HOSPITAL,581110
    8095441380 Haveri Circle
    45265 M/s. Punyakoti Medical
    and General Stores
    Katha No.1392,Ground
    floor,Opp.Govt Hospital, Main
    road563139
    9448722271 Kolar Circle
    20209 M/s.Apollo Hospital
    Enterprises Ltd Unit of
    Apollo Pharmacy
    Survey
    no:3571/3441/2878,Shop no04MC road563131
    9999999999 08159243344 Kolar Circle
    44064 NEW SRI SAI GANESH
    PHARMA
    PROP NO: 2-1-66, GROUND
    FLOOR, WARD NO: 03,SRI
    SHARANABASAVESHWARA
    TEMPLE ROAD, NEAR
    ESHWAR TEMPLE,583229
    9480794140 Koppal Circle
    45261 APOORVA MEDICAL &
    GENERAL STORES
    PROP NO: 9-3-72/2, WARD
    NO: 04,BEHIND GOVT. CHC
    HOSPITAL,583232
    9538491363 Koppal Circle
    41399 Adichunchanagiri
    Hospital Pharma
    no-2, sy no-42/E, gd
    flr,Adichunchanagiri hospital &
    Research centres
    premises571448
    9742574778 Mandya Circle
    46065 Sri Kalabhyraveshwara
    Pharma
    K no-D6/2373/9648/361/A, 2nd
    flr, 2nd rossNehru nagar
    9945629834 Mandya Circle
    13358 Trust Chemist &
    Druggist Limited
    2, Sri Adichunchanagiri Hospital
    & Research centre,N.H.48,
    B.G.Nagar
    9845226989 Mandya Circle
    37566 Vikram Pharma K.No-1220,(D5/271/1219B) &
    (D5/272/1220), gd flrVikram
    Hospital Premises, 3rd Cross,
    Ashok nagar
    9008489261 0821-241212 Mandya Circle
    24401 KMC HOSPITAL
    MEDICAL STORES,((A
    UNIT OF MANIPAL
    ENTERPRISES
    DOOR NO.14-3-211/3,
    GROUND
    FLOOR,DR.AMBEDKAR
    CIRCLE,575001
    9901677117 0824-2444590 Mangalore Circle

    40874 M/s Yenepoya Medical
    College Hospital Medical
    Stores ( Yenepoya
    University)
    D.No.2-331/15, Room No. 3 D
    Wing, Basement FloorYenepoya
    Medical College Hospital575018
    9249436909 Mangalore Circle

    42649 M/s. RADHA
    MEDICALS ( A UNIT
    OF SAI RADHA
    PHARMA (I) PVT. LTD.,
    DOOR NO. 4-6-574/11-14,
    GROUND FLOOR, BRIGADE
    PLAZA,K.R. RAO ROAD,
    KARANGALPADY,575003
    9243310605 Mangalore Circle

    45869 MYSORE MEDICALS # 891/2, OPPOSITE
    VAATSALYA
    HOSPITAL,N.S.ROAD,
    LAKSHMIPURAM570004
    8095831607 Mysore Circle 2
    44814 SRI. CHAMUNDI
    PHARMA
    # 452, SHOP # 1, 1ST
    FLOOR,CHAVADI STREET,
    M.G.ROAD570004
    9900252833 Mysore Circle 2
    43213 ISH KRUPA NO. 2/1, PEER KHAN
    STREETOFF CHAMUNDI
    VIHAR STADIUM,
    NAZARBAD570010
    9480029837 Mysore Circle 2
    43496 ARYAN PANACEA SHOP NO. 4, # 199, B
    BLOCK10TH MAIN ROAD,
    J.P.NAGAR570008
    9743514071 Mysore Circle 2
    45222 SURGICAL
    CORPORATION
    31/A, MASHALLAH COMPLEX,
    MAHDEVPURA HUDCO
    EXTENSIONLASHKAR
    MOHALLA, UDAYAGIRI570019
    9448281723 Mysore Circle 2
    46041 AAYUSHMAN
    MEDICALS
    # 2/206,
    DEVAIYANAHUNDI,SRIRAMPU
    RA, 2ND STAGE,570023
    9916688379 Mysore Circle 2
  • 45945 VENKATESHWARA MEDICALS
    # 42, SHOP # 2, 1ST MAIN,2ND
    CROSS, J.C.NAGAR,570011
    9901996913 Mysore Circle 2
  • 44508 DRUG CENTRE, JSS HOSPITAL[ JSS MEDICAL SERVICES TRUST]
    # 1219, FIRST FLOOR, JSS
    HOSPITAL,M.G.ROAD,570004
    9900182215 Mysore Circle 2
    23925 KARNATAKA MEDICAL
    & GENERAL STORES
    SHOP NO. 6-1-70 (O), 6-1-81
    (N)MAIN ROAD,
    9972891260 Raichur Circle
  • 34997 IMPANA MEDICALS KHATA NO.
    835A/15/86A/411/598/311A, GR
    FLIMPANA HOSPITAL,
    VIVEKANANDA NAGAR, B M
    ROAD,562159
    948880996 Ramanagara
    Circle
    39450 APARNA MEDICALS
    AND GENERAL
    STORES
    ROOM NO 03, S NO 36/1A,
    GROUND FLOOR,W
    NO04HOLEHONNUR ROAD
    VIDYA NAGAR
    9449699193 Shimogga Circle
  • 43354 OLO GOOD HEALTH
    PHARMA
    Ward No:19, Khata No:208-198-
    248 & 209-199-249,3rd Floor,
    Louisa Mansion, Old Post Office
    Road577202
    9916024333 Shimogga Circle
  • 45923 Malleshwara Pharma W No 8, K No 526-525-37-38/4,
    Shop No 1, Bellibetta
    Complex,Basaveshwar Nagar,
    2nd Cross, Savalanga
    Road,577201
    9916124199 Shimogga Circle
  • 46231 SARJI PHARMA W No 5, Plot No 11, UPOR No
    S12-5786, Ground Floor,Sarji
    Hospital Premises, R.M.R.
    Road, Park Extension,577201
    9448899572 Shimogga Circle

Function of hospital – PPT PDF – General Primary Basic Role

function of hospital

Before studying function of hospital first let us know what is hospital.

“The’hospital is an integral part of a social and medical organization, the function of which is to provide the population complete health care, both curative and preventive, and whose out-patient services reach out to the family in its home environment; the hospital is also a centre for the training of health workers and for bio-social research.”

what is primary function of a hospital

What are the basic role and functions of a hospital?

  • Patient care
  • Public health care
  • Education services
  • Research

General functions of hospitals:

  • Medical services
  • Administrative services
  • Patient care & education
  • diagnosis, treatment of illness
  • rehabilitation
  • convalescent care

Major functions of hospitals:

  • Treatment and management of patients
  • Patient care with nursing, dietary diagnostic, therapy, pharmacy and laboratory services.
  • Management & Administrative services

Function of hospital pharmacy:

The prime objectives and functions of hospital pharmacy are cost containment, patient satisfaction, effective staff utilization and effective and efficient services

  • Managing the use of medications in hospitals and other medical centers
  • Advising both patients and other health professionals about the safe and effective use of medicines
  • Choosing, preparing, storing, compounding and dispensing medications for patients in a medical environment
  • Prescription, procuration, delivery, administration and review of medications to optimize patient outcomes
  • Ensure correctness patient, dose, route of administration, time, drug, information and documentation

Role and function of hospital PPT

Function of clinic:

  • Clinics are particular blocks of time set aside for a team of healthcare professionals to see patients together
  • Hospital clinics are primarily concerned with acute diseases, and the physicians in the clinics are usually the same physicians who treat inpatients in the hospital.
  • Individual practitioner plus the benefit of group consultation, have encouraged the establishment of clinics
  • Promote prompt and reliable medical attention.

FUNCTIONS OF A HOSPITAL PHARMACIST

  1. To provide and evaluate pharmaceutical services
  2. To draw a plan for hospital pharmacy administration
  3. To establish liaison between administrative authorities and medical Doctors.
  4. To estimate the requirements for the department and enforce the policies and procedures for the recruitment of adequate and competent staff
  5. To develop and maintain an effective system of clinical and administrative records and reports
  6. To participate in and adhere to the financial plan of the operation for the hospital

UGC Indexed Journals Approved Care List PDF

Here we present UNIVERSITY GRANTS COMMISSION approved and indexed Journals which are called UGC Care list. Pharmacy UGC Journals New Updated journals with high impact factor. The cost for these journals might be different some might be low cost and some can be at a higher end. 2020 2021. Pharmacy UGC approved journals need to be first verified before you contact them in the official website of University Grants Commission.  

UGC indexed journals – Approved List

  • Pharma Science UNIV Science Pharma Science Monitor
  • journal of Hospital and Clinical Pharmacy UNIV Science Wiley-Blackwell Publishing Ltd 22296921 India
  • Int J Ayu Pharm Chem (IJAPC) UNIV Science Green Tree Group
  • American Journal of Pharmacological Sciences UNIV Science Science and Education Publishing Co. Ltd 23276711 2327672 United States
  • Bulletin of Faculty of Pharmacy, Cairo University UNIV Science Faculty of Pharmacy, Cairo University 1110093 Egypt
  • Indo Global Journal of Pharmaceutical Sciences UNIV Science Rajeev K Singla, Ed.& Pub. 22491023 India
  • Pharmacophore An International Research Journal UNIV Science Jadoun Science Publishing Group 22295402 India
  • International journal of Medicinal Chemistry UNIV Science Hindawi 20902069 20902077 India
  • Tuberculosis Research and Treatment UNIV Science Hindawi, US 2090150x Egypt 44575
  • Open Pharmaceutical Sciences Journal UNIV Science Bentham Open 18748449 U.A.E
  • Journal of Pharmacognosy &Phytochemistry UNIV Science Society of Pharmacognosy and
  • Phytochemistry 23498234 22784136 India
  • Functional Foods in Health and Disease UNIV Science Functional Food Center, Inc. 21603855 United States
  • UNIVERSITY GRANTS COMMISSION approved and indexed Journals pdf
  • Current Pharma Research UNIV Science Unicorn Publications, India 22307842 India Inventi Rapid Molecular Pharmacology
  • Journal of Drug Delivery and Therapeutics UNIV Multidisciplinary Society of Pharmaceutical Technocrats 22501177 IndiaUNIV Science Inventi Journals Pvt. Ltd 22294171 09763856 India
  • Journal of New Results in Science UNIV Science Gaziosmanpasa University 13047981 Turkey
  • Pharmaceutical Nanotechnology UNIV Science Bentham Science Publishers Ltd 22117393 U.A.E
  • The Pharma Innovation Journal UNIV Science AkiNik Publications,AkiNik Publications India
  • International Journal of Pharmacy and Biological Sciences UNIV Science Jayapal Reddy Gangadi, Ed. & Pub. 22307605 India
  • journal of Pharmasceutical and scientific innovation UNIV Science Moksha Publication 22774572 India
  • Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and Chemical Sciences (RJLBPCS)UNIV Science Jaysingpur India
  • International Research Journal of Humanities, Engineering & Pharmaceutical Sciences, UNIV Social Science Gayatri Publications India
  • Journal of Pharmaceutical ,Chemical and Biological Sciences UNIV Science : www.jpcbs.info India
  • Asian Journal of Pharmaceutical Biochemical Research UNIV Science Dr Bharat Parashar 22312560 India
  • International Journal of Pharmaceutical and Biological UNIV Science Mandsaur Institute of Pharmacy 09763333 India
  • Pharmaceutical Methods UNIV Science Phcog.Net India
  • International Journal of Pharmaceutical investigation UNIV Science Medknow Publication and media pvt. Ltd 2230973 India
  • Asian Journal of Pharmacy and Pharmacology UNIV Science Pharmaceutical research information group 24552674 India
  • International journal of Pharmaceutical Research UNIV Science Association of Indian Pharmacist 09752366 India
  • Medicines, Ethics and Practice UGC Science Royal Pharmaceutical Society United Kingdom
  • International Journal of Bio Pharma Research UNIV Science International journal of biopharma and research 22876898 India
  • Future journal of pharmaceutical sciences UNIV Science Elsevier 23147245 United Kingdom
  • Journal Biosciences and Technology UNIV Science Pharma Info Publications 09760172 India
  • International Journal Pharmacology, phytochemistry and ethnomedicine UNIV Science Scipress 22976922 22976922 Switzerla
  • Asian Journal of Research in Chemistry and Pharmaceutical Sciences UNIV Science Uptodate Research Publications, India 23497106 India

UNIVERSITY GRANTS COMMISSION approved and indexed Journals pdf

UGC care list of journals pdf will be provided here soon. Updated journals list 2020 to publish Pharmaceutics, Pharmacology, Pharmacognosy, Pharmaceutical analysis, Pharmaceutical chemistry.

Good Clinical Practice (GCP) Inspection Preparation & Guidance for Clinical Trials Units #PPT PDF

Good Clinical Practice (GCP) Inspection Preparation & Guidance for Clinical Trials Units #PPT PDF

Good Clinical Practice (GCP) Inspection Preparation and Guidance for Clinical Trials Units is a GCP INSPECTION CHECKLIST is here to help registered clinical trial units. This article is for guidance only and is not intended to replace information or advice from the Government. It is always recommended  check official site  Central Drugs Standard Control Organization for advice and guidance in order to be aware of current guidance.

I. General

Good Clinical Practice (GCP) Inspection General Checklist

  1. Name and address of the clinical trial site
  2. Date of Inspection
  3. Inspection Team Members:
  4. Personnel present during Inspection (with name and role/designation.)
  5. Address & Contact details of Investigator:
  6. Name & address of the Sponsor
  7. Name & address of clinical trial NOC holder
  8. Name & address of EC
  9. Protocol Title
  10. Protocol Number
    Version/date
    Protocol amendments, if any.
  11. Investigational Product
  12. Stage of study:
    (Mark the relevant)
    (A) Before Trial Commencement
    (B) During Conduct of the trial
    (C) After Completion of Trial
  13. Type of Inspection:
    Surveillance
    For CauseGood Clinical Practice (GCP) Inspection Preparation & Guidance for Clinical Trials Units #PPT PDF

II.LEGAL & ADMINISTRATIVE ASPECTS: GCP checklist

  1. Clinical trial NOC from O/o DCGI
    (Note: mention along with Protocol no., Ver., date)
  2. NOC for subsequent protocol amendments, if any from O/o DCGI
  3. Ethics Committee approval date
    (Note: mention along with Protocol no., Ver., date)
    Appendix VII as per Sch.-Y
    (mention revision(s) and notification to O/o DCGI, if any)
  4. Whether valid financial agreement between the Sponsor, Investigator & Institution available.
  5. Whether liability of involved parties (Investigator, Sponsor and Institution) clearly agreed.
  6. Is the valid clinical trial Insurance available?
  7. Site Initiation date
  8. Date of screening of first subject,
  9. Date of signing ICF by the first subject
  10. Date of Last Patient-Last Follow-Up (if applicable)
  11. Whether SOP for various activities are established and documented.
  12. Verify, whether the hospital/institute/site has adequate emergency care facilities to handle emergency situation.
  13. Good Clinical Practice (GCP) Inspection Preparation & Guidance for Clinical Trials Units #PPT PDF

III Organisation & Personnel

GCP Inspection Checklist for Organisation & Personnel

  1. Assure that signed & dated, Curriculum Vitae is available for the Investigator, Sub Investigator /Co-Investigator
  2. Confirm the educational qualification of the Investigator with registration by Medical Council of State/India.
  3. Confirm the GCP, Schedule Y and protocol specific training of Investigator, Sub-Investigator/Co-Investigator and its team.
  4. Determine whether authority for conducting various clinical trial activities were delegated properly by
  5. Investigator to competent personnel (obtain the list of personnel and duty delegation log).
    Check whether the person whom the authority is delegated is adequately qualified and trained for the activity/activities assigned.
  6. Obtain the list of all clinical trials performed by Investigator (Preferably for last three years)
  7. Ensure that the Investigator is involved in conduct of not more than three clinical trials at a time.

IV Conduct of Trial

GCP Inspection Checklist for Conduct of Trial

A.Screening of subjects:

  1. Check and review the informed consent for the screening of the subjects.
  2. Check site screening log & enrolment log and obtain authenticated copy.
  3. Check whether the subjects are meeting the inclusion/exclusion criteria as per the approved protocol w.r.t review of source documents &/or CRF.

3.1 Clinical Examination by Investigator ( Check patient file/Source documents)

3.2 Verify ,Clinical Laboratory Evaluation( Check Blood Cell Counts, Biochemical test, Urine analysis etc.as required by protocol)

3.3 Verify X-Ray, MRI, ECG, USG or any other technique required to ascertain the inclusion/exclusion criteria.

3.4 Verify, Whether all conditions of Clinical trial NOC are followed or not?

B. Subject record and Informed consent:

  1. Whether ICF have all the elements enlisted in Appendix V of Schedule Y.
    Whether ICF is approved by Ethics Committee prior to consent process.
  2. Whether IC has been obtained from each subject prior to participation of the subject in the study.
  3. Whether signature/thumb impression of the subjects/legal representative have been affixed with date.
  4. Whether in case of illiterate subjects or illiterate representative of a subject, there are signature and details of an impartial witness.
  5. Have witness/ signature being personally dated.( If applicable).
  6. Have patient/witness signature been personally dated?
  7. Has the dated signature of the designated person for administering informed consent (IC) been affixed?
  8. Is the designated person for administering IC medically qualified?
  9. If IC has been administered by a designated person who is not medically qualified, is there evidence that subject’s queries of a medical nature were answered by a medically qualified person or the investigator?
  10. Is the completed ICF signed and dated by the investigator?
  11. Check weather re-consenting is done for changes in ICF, if any.

B.1 Audio-Visual recording of Informed Consent Process( For ‘vulnerable population’ in ‘New Chemical Entities (NCEs) clinical trial’ only & Anti HIV & Anti-Leprosy patients only Audio recording) ( Verify as per GSR 611(E) dated 31.07.2015 )

  1. Whether audio-visual recording is performed for all subjects, independently.
  2. Is audio-visual recording conducted in a room conducive to recording of disturbance free audio and video of the consent process?
  3. Check whether the video recording is free from disturbance to ensure that the image is recognizable and the audio is clearly audible.
  4. Check whether the recording of informed consent process is preserved safely.

C. Source Documents and Case Record Form

  1. Verify condition, completeness, legibility, accessibility of the investigators source data file. ( source data includes study subject’s files, recording from automated instruments, tracings, X-ray and other films, laboratory notes, photograph negatives, magnetic media, hospital records, clinical and office charts, subject’s diaries, evaluation checklists and pharmacy dispensing records)
  2. Whether subject received the test drug with respect to dose and frequency according to the protocol;
  3. Determine whether safety/ efficacy end point data( Clinical, laboratory examination results) were collected and reported in accordance with the protocol
  4. Does medical record mentions subject ID/ name /hospital registration number / and indication that subjects are participating in a clinical trial
  5. Compare the source document with CRF and determine whether source data have been correctly transcribed in CRF;
  6. Verify the drop-outs and reason for drop-out of subject is appropriately recorded.
  7. Whether the withdrawal of subject from the study is recorded and appropriately justified in accordance with approved protocol.
  8. Verify whether Standard Operating Procedure of handling of Serious Adverse Event occurred in clinical trial is available.
  9. Verify whether all SAE’s have been reported to the sponsor, EC and Licensing authority as per the timelines in accordance with Schedule Y.
    (Verify as per GSR 53(E) dated 30.01.2013 & GSR 889 (E) dated 12.12.14 effective from 12.06.2015 )
  10. Verify Whether SOP for medical care during serious adverse event is available or not.
  11. Verify whether adequate medical care have been given to the subject especially in the event of inter current illness, adverse events including abnormal lab parameters;
  12. Verify whether all study related activities are performed at site approved by O/o DCGI.

VI. Sponsor

  1. all report submitted to the sponsor;
  2. Whether all CRF were submitted to sponsor after completion of study;
  3. Determine whether all dropout and reason thereof were reported to sponsor;
  4. Determine the method and frequency of monitoring the progress of the study by the sponsor and corrective action by site.
  5. Whether sponsor appointed a monitor with appropriate qualification and experience to monitor trial at the site.
  6. Whether a log of onsite monitoring visit is maintained at the site.
  7. Is monitor submits visit report with deviations if any to the sponsor.
  8. Whether sponsor performed an audit as a part of QA in order to independent and separate from routine monitoring of quality control function.
  9. In case the investigator and sponsor agrees to prematurely terminate or suspend the study for any reason, whether it was promptly informed to study subjects, Ethics Committee and Licensing Authority.

VII. Investigational Product

GCP Checklist for Investigational Product

  1. Whether investigator maintain copies of Review individual subject record to verify the correct dose administration with respect to dose, frequency, route of administration
  2. Determine whether unqualified /unauthorised persons administered/dispensed the test drug
  3. Determine whether adequate record of quantity of test drug received , dispensed is maintained.( Check the test drug reconciliation and verify the leftover drug or balance on the day of inspection).
  4. Determine whether storage condition/monitoring method are as per protocol/recommendation;
  5. Whether trial medication are maintained in secured manner with controlled access
  6. Have un-used trial medications been returned to the sponsor or disposed of according to protocol?
  7. Are the drugs dispensing records being maintained properly?
  8. Whether the records for reconciliation of all IP’s are maintained?
  9. Are electronic or hand-written temperature logs available for the storage area of the investigational products?
  10. Verify that investigation product is appropriately labelled. (For clinical trial use only).

VIII. Ethics Committee

GCP INSPECTION CHECKLIST on Ethics Committee

  1. Identify the name, address of the EC/ IEC in the approval letter and compare it with one stated in Investigator Undertaking.
  2. Verify the Status of EC-whether Institutional or Independent, Check Registration certificate ( Verify as per GSR 72(E) dated 08.12.2013)
  3. Verify if EC approval letter mention study code , title and version number of the protocol, list of other documents reviewed, list of members present at the meeting, quorum of five members as specified in Schedule Y satisfied, date, time , venue of the meeting, signature and date of member secretary / Chairman.
    Verify whether the EC recorded minutes of meeting.
  4. Verify whether EC is performed on site monitoring of the clinical trial approved.
    (Frequency and SOP)
  5. Verify whether EC members have conflict of interest in the approved trial, if yes then the member should abstain from such approval meeting.
  6. Verify whether the communications between Investigator and EC are available for changes, Serious Adverse Event and deviations occurred in clinical trial.
  7. Verify whether EC is function in accordance with conditions of registration by LA.

IX Pathology Laboratory ( for Screening/ Assessment)

  1. Name and address of the clinical laboratory used in the study. (Local and Outside).
  2. Whether financial & Confidentiality agreement with Investigator and concerned laboratory (ies) in place.
  3. Is investigator/Sponsor verified the accreditation status and adequacy of the facilities to perform the specified tests as per protocol.
  4. Verify whether the SOP for sample preparation, handling and transportation is available. Verify the appropriateness of the SOP.

X Quality Assurance

  1. Verify whether SOP for all procedures conducted at site are available i.e. have a copy of Site Specific and Trial specific SOPs
  2. Verify the essential components of SOP like who prepared, checked, authorized and when, frequency of SOP revision
  3. Whether SOPs for all operation like screening and Informed consent Process, AV recording of ICP of vulnerable population in NCE-CTs, SAEs & its Management, Communication with EC/Sponsor/CDSCO, GCP/Sch.Y, training to trial team, training assessment
  4. Whether SOPs for all operation like IP handling and distribution to study subjects, blood samples collection, processing preservation and transportation to local laboratory.
  5. Whether SOPs for all operation of storage cabinets, refrigerators/deep freezers used to store samples and IP are available.
  6. Verify, whether records for job description/responsibilities, qualification and training for all personnel involved in the clinical trial is maintained and stored.
  7. Verify whether the activities performed are in compliance with duty delegated by Investigator.
  8. Verify whether concern staff is adequately trained and records maintained there of
  9. In case of vaccines, are a spillage SOP available and the study team trained to handle such an incidence?

XI Record keeping and data handling

  1. Is adequate space available for document retention?
  2. Determine whether documents are maintained properly and for the period as specified.
  3. Whether necessary measures have been taken to prevent accidental or premature destruction.
  4. Whether the archival access controlled or restricted to authorized personnel.
  5. Weather SOP available to document all steps in data management in order to allow step by step retrospective assessment of data quality and study performance.
  6. Whether corrections in documents carry the date and initials of Investigators and authorized person.

XI-a Electronic data processing

  1. Is electronic data processing is done by authorized person?
  2. Verify whether list of authorized persons to make changes is maintained
  3. Verify if provision for recording of trail of changes and deletions made is available.
  4. Whether the hardware and software use for data recording and processing is validated

Important NOTE Collect authenticated copies as exhibit wherever any Critical &/or Major non-compliance has been observed.

Drugs Technical Advisory Board – DTAB – Functions Members Tenure Works

What is Drugs Technical Advisory Board?

The Drugs Technical Advisory Board advises the Central Government and the State Governments on technical matters arising out of the administration of Drugs & Cosmetics Act and carry out functions assigned to it by this Act. 

Who are the members of DTAB Drugs Technical Advisory Board? 

(i) the Director General of Health Services, ex officio, who shall be Chairman;

(ii) the Drugs Controller, India, ex officio;

(iii) theDirector of the Central Drugs Laboratory, Calcutta, ex officio;

(iv) the Director of the Central Research Institute, Kasauli, ex officio; 

(v) the Director of Indian Veterinary Research Institute, Izatnagar, ex officio;

(vi) the President of Medical Council of India, ex officio;

(vii) the President of the Pharmacy Council of India, ex officio;

(viii) the Director of Central Drug Research Institute, Lucknow, ex officio;

(ix) two persons to be nominated by the Central Government from among persons who are in charge of drugs control in the States; one person, to be elected by the Executive Committee of the Pharmacy Council of India, from among teachers in pharmacy or pharmaceutical chemistry or pharmacognosy on the staff of an Indian university or a college affiliated thereto;

(xi) one person, to be elected by the Executive Committee of the Medical Council of India, from among teachers in medicine or therapeutics on the staff of an Indian university or a college affiliated thereto;

(xii) one person to be nominated by the Central Government from the pharmaceutical industry;

(xiii) one pharmacologist to be elected by the Governing Body of the Indian Council of Medical Research;

(xiv) one person to be elected by the Central Council of the Indian Medical Association;

(xv) one person to be elected by the Council of the Indian Pharmaceutical Association;

(xvi) two persons holding the appointment of Government Analyst under this Act, to be nominated by the Central Government.

Functions of Drugs Technical Advisory Board

1. Co-ordinate the DTAB meetings under the Chairmanship of Director General of Health Services (DGHS) to advise the Central Government and the State Governments on technical matters arising out of the administration of the Drugs and Cosmetics Act, 1940 and to carry out the other functions assigned to it by this Act.

2. Co-ordinate the DCC meetings under the Chairmanship of Drugs Controller General (India) to advise the Central Government, the State Governments and DTAB on any other matter tending to secure uniformity throughout India in the administration of the Drugs and Cosmetics Act, 1940.

3. Initiate the amendments in the Drugs and Cosmetics Rules, 1945 as per the recommendations of DTAB and co-ordinate with Ministry of Health & Family Welfare (MOHFW) for draft and final Gazette Notifications.

4. Examination, compilation and consideration of comments/suggestions/objections received with respect to draft Gazette Notifications / Public Notices / Circulars etc.

5. Co-ordinate the constitution of sub-committees recommended in DTAB and DCC meetings and further follow-up for their reports.

6. Co-ordinate the stake holders meetings with respect to amendments of Drugs and Cosmetics Rules, as per recommendations from MOHFW whenever required.

7. Prepare minutes of DTAB and DCC meetings and upload on CDSCO website for stakeholders/public reference.

8. Processing of representations/RTIs/Public Grievances with respect to Drugs and Cosmetics Act and Rules thereunder

Tenure of Drugs Technical Advisory Board Members? 

The nominated and elected members of the Board shall hold office for three years, but shall be  eligible for renomination and re-election:

1 [Provided that the person nominated or elected, as the case may be, under clause (ix) or clause (x) or clause (xi) or clause (xvi) of sub-section

(2) shall hold office for so long as he holds the appointment of the office by virtue of which he was nominated or  elected to the Board.]

(4) The Board may, subject to the previous approval of the Central Government, make bye-laws fixing a quorum and regulating its own procedure and the conduct of all business to be transacted by it.

(5) The Board may constitute sub-committees and may appoint to such sub-committees for such periods, not exceeding three years, as it may decide, or temporarily for the consideration of particular matters, persons who are not members of the Board.

Organogram of DTAB

How DTAB Works ?  Processes

BY-LAWS OF THE DTAB:

1. The Chairman of the Board shall fix the date, time and place of every meeting of the Board, provided that the Board shall meet at least once every calendar year.

2. The Chairman of the Board shall, when present, preside all the meetings of the Board. If the Chairman is not present in any meeting, the members present shall select from amongst themselves a person to preside as Chairman at such meeting.

3. Seven member of the Board present in person shall constitute a quorum.

4. (i) Not less than 35 clear days’ notice of every meeting shall be given to each member of the Board, provided that the Chairman:-
(a) may call, after giving not less than 15 clear days’ notice to the members of the Board, a special meeting at any time to deal with any urgent matter requiring the attention of the Board;
(b) shall call, after giving not less than 15 clear days’ notice to the members of the Board, a special meeting within one month of the receipts of a requisition in writing signed by not less than seven members and stating the purpose, being a purpose within the scope of the Board’s functions for which they desire the meeting to be called.
(ii) The notices shall be dispatched to the latest address given to the Secretary by the members of the Board.

5. Any member desirous of moving any resolution at a meeting of the Board shall give notice, thereof in writing to the Secretary not less than 15 days before the date of such meeting, provided that in the case of a special meeting the notice will not be less than 5 days.

6. Each member of the Board shall have one vote, and if there shall be an equality of votes on any question to be decided, the Chairman shall have a second or casting vote.

7. Any business, which it may be necessary for the Board to discuss and decide except such as the Chairman may direct to be transacted by circulation among all members of the Board shall be placed at a meeting of the Board. If three or more members express, in writing, a desire that any particular subject shall be discussed at a meeting instead of being decided by circulation it shall be placed before a meeting of the Board.

8. Any resolution or report which is circulated on the direction of the Board or by the Chairman under Bye-Laws 7, and approved by a majority of the members signing shall be as binding as a resolution voted in a meeting of the Board, provided that at least nine members of the Board shall have recorded their views on the resolution in support.

9. Proceedings of each meeting, duly approved by the Chairman, shall be forwarded to the members of the Board for their approval or comments within 35 days of the date on which the meeting was held.

10. The quorum for a sub-committee appointed by the Board shall be determined at the time of the appointment of the sub-committee and shall not be less than a majority of the members appointed.

11. The Chairman and the Secretary of the Sub-committee shall be appointed by the Board at the time of the appointment of the sub-committee.
980529/2018/CDSCO-(HQ)

Pharm. D – Course Syllabus Duration-Doctor of Pharmacy Scope- #Exams

Pharm. D - Course Syllabus Duration-Doctor of Pharmacy Scope- #Exams

Doctor of Pharmacy Scope Academic Regulations for Pharm. D and D (Post Baccalaureate) (Regular)

(Effective for the students admitted into I year from the Academic Year onwards)

 

Award of Pharm. D Degree

 

A student will be declared eligible for the award of the Pharm. D. Degree if he fulfils the following academic regulations:

i. Duration of the course Pharm D

 

  1. D: The duration of the course shall be six academic years (five years of study and one year of internship or residency) full time with each academic year spread over a period of not less than two hundred working days. The period of six years duration is divided into two phases –

 

 

Phase  I   –    consisting of First, Second, Third, Fourth and Fifth academic year.

 

Phase II – consisting of internship or residency training during sixth year

Involving posting in speciality units. It is a phase of training wherein a student is exposed to actual pharmacy practice or clinical pharmacy services and acquires skill under supervision so that he or she may become capable of functioning independently.

 

  1. Pursue the course of study for not less than 06 academic years and is not more than 12 years.

 

  1. Students, who fail to fulfil all the academic requirements for the award of the degree within 12 academic years from the year of their admission, shall forfeit their seat in Pharm D. course and their admission is cancelled.

 

  1. A student will be declared eligible for the award of the D (Post Baccalaureate). Degree if he fulfils the following academic regulations:

 

  1. D. (Post Baccalaureate): The duration of the course shall be for three academic years (two years of study and one year internship or residency) full time with each academic year spread over a period of not less than two hundred working days. The period of three years duration is divided into two phases –

Pharm. D - Course Syllabus Duration-Doctor of Pharmacy Scope- #Exams

Phase  I   –    consisting of First and Second academic year.

 

Phase II – consisting of Internship or residency training during third year involving posting in speciality units. It is a phase of training wherein a student is exposed to actual pharmacy practice or clinical pharmacy services, and acquires skill under supervision so that he or she may become capable of functioning independently.

 

  1. Pursue the course of study for not less than 03 academic years and is not more than 06 years.

 

  1. Students, who fail to fulfil all the academic requirements for the award of the degree within 06 academic years from the year of their admission, shall forfeit their seat in Pharm D (PB) course and their admission is cancelled.

 

 

  1. Every year there shall be an examination to examine the students.

 

  1. Each examination may be held twice every year. The first examination in a year shall be the annual examination and the second examination shall be supplementary examination.

 

  1. The examinations shall be of written and practical (including oral nature) carrying maximum marks for each part of a subject as indicated in Tables below :

TABLES

First Year examination :

 

S.No.Name of SubjectMaximum marks for TheoryMaximum marks for Practicals
         
   ExaminationSessionalTotalExaminationSessionalTotal
         
1.1HumanAnatomy70301007030100
 and Physiology      
1.2Pharmaceutics70301007030100
1.3Medicinal 70301007030100
 Biochemistry      
1.4Pharmaceutical70301007030100
 Organic Chemistry      
1.5Pharmaceutical70301007030100
 Inorganic Chemistry      
1.6Remedial 703010070*30*100*
 Mathematics/      
 Biology       
     600  600 =
        1200

 

* for Biology.

 

Second Year examination Pharm D :

 

S.No.Name of SubjectMaximum marks for TheoryMaximum marks for Practicals
        
  ExaminationSessionalTotalExaminationSessionalTotal
        
2.1Pathophysiology7030100
2.2Pharmaceutical70301007030100
 Microbiology      
2.3Pharmacognosy &70301007030100
 Phytopharmaceuticals      
2.4Pharmacology-I7030100
2.5Community Pharmacy7030100
2.6Pharmacotherapeutics-70301007030100
 I      
    600  300 =
       900

 

 

 

Third Year examination :

 

S.No.Name of SubjectMaximum marks for TheoryMaximum marks for Practicals
        
  ExaminationSessionalTotalExaminationSessionalTotal
        
3.1Pharmacology-II70301007030100
3.2Pharmaceutical70301007030100
 Analysis      
3.3Pharmacotherapeutics-70301007030100
 II      
3.4Pharmaceutical7030100
 Jurisprudence      
3.5Medicinal Chemistry70301007030100
3.6Pharmaceutical70301007030100
 Formulations      
    600  500 =
       1100

 

 

 

 

Fourth Year examination :

 

S.No.Name of SubjectMaximum marks for TheoryMaximum marks for Practicals
        
  ExaminationSessionalTotalExaminationSessionalTotal
        
4.1Pharmacotherapeutics-70301007030100
 III      
4.2Hospital Pharmacy70301007030100
4.3Clinical Pharmacy70301007030100
4.4Biostatistics &7030100
 Research      
 Methodology      
4.5Biopharmaceutics &70301007030100
 Pharmacokinetics      
4.6Clinical Toxicology7030100
    600  400 =
       1000

 

Fifth Year examination :

 

S.No. Name of SubjectMaximum marks for TheoryMaximum marks for Practicals
         
  ns ExaminationSessionalTotalExaminationSessionalTotal
         
5.1 Clinical Research7030100
5.2 Pharmacoepidemiology7030100
  and      
  Pharmacoeconomics      
5.3 Clinical7030100
  Pharmacokinetics  &      
  Pharmacotherapeutic      
  Drug Monitoring      
5.4 Clerkship *7030100
5.5 Project work (Six100**100
  Months)      
      300  200 =
         500

 

  • Attending ward rounds on daily basis.
  • 30 marks – viva-voce (oral)

70 marks – Thesis work

Attendance requirements

 

Eligibility for appearing Examination.― Only such students who produce certificate from the Head of the Institution in which he or she has undergone the Pharm.D. or as the case may be, the Pharm.D. (Post Baccalaureate) course, in proof of his or her having regularly and satisfactorily undergone the course of study by attending not less than 80% of the classes held both in theory and in practical separately in each subject shall be eligible for appearing at examination.

 

Mode of examinations

 

  • Theory examination shall be of three hours and practical examination shall be of four hours duration.

 

  • A Student who fails in theory or practical examination of a subject shall re-appear both in theory and practical of the same subject.
  • Practical examination shall also consist of a viva –voce (Oral) examination.

 

  • Clerkship examination – Oral examination shall be conducted after the completion of clerkship of students. An external and an internal examiner will evaluate the student. Students may be asked to present the allotted medical cases followed by discussion. Students’ capabilities in delivering clinical pharmacy services, pharmaceutical care planning and knowledge of therapeutics shall be assessed.

 

Award of sessional marks and maintenance of records

 

  • A regular record of both theory and practical class work and examinations conducted in an institution imparting training for Pharm.D. or as the case may be, Pharm.D. (Post Baccalaureate) course, shall be maintained for each student in the institution and 30 marks for each theory and 30 marks for each practical subject shall be allotted as sessional.

 

  • There shall be at least three periodic sessional examinations during each academic year and the highest aggregate of any two performances shall form the basis of calculating sessional marks.

 

  • The sessional marks in practicals shall be allotted on the following basis:-

(i)  Actual performance in the sessional examination               (20 marks);

(ii) Day to day assessment in the practical class work,

 

promptness, viva-voce record maintenance, etc.                 (10 marks).

 

Minimum marks for passing Pharm D examination.―

 

A student shall not be declared to have passed examination unless he or she secures at least 50% marks in each of the subjects separately in the theory examinations, including sessional marks and at least 50% marks in each of the practical examinations including sessional marks. The students securing 60% marks or above in aggregate in all subjects in a single attempt at the Pharm.D. or as the case may be, Pharm. D. (Post Baccalaureate) course examination shall be declared to have passed in first class. Students securing 75% marks or above in any subject or subjects shall be declared to have passed with distinction in the subject or those subjects provided he or she passes in all the subjects in a single attempt.

Eligibility for promotion to next year.―

 

All students who have appeared for all the subjects and passed the first year annual examination are eligible for promotion to the second year and, so on. However, failure in more than two subjects shall debar him or her from promotion to the next year classes.

 

 

 

  • Internship is a phase of training wherein a student is expected to conduct actual practice of pharmacy and health care and acquires skills under the supervision so that he or she may become capable of functioning independently.

 

  • Every student has to undergo one year internship as per PCI norms for Pharm D (Appendix A).

 

  1. 10. Practical training

 

As per PCI norms for Pharm D (Appendix B)

 

  1. Transitory regulations:

 

Candidates who have been detained for want of attendance or not fulfilled academic requirements or who have failed after having undergone the course in earlier regulations or have discontinued and wish to continue the course are eligible for admission into the unfinished semester from the date of commencement of class work with the same or equivalent subjects as and when subjects are offered, subject to Section 2. and continue to be in the academic regulations they were first admitted.

 

  1. With – holding of results:

 

If the candidate has not paid dues to the university or if any case of in-discipline or malpractice is pending against him, the result of the candidate shall be withheld and he will not be allowed / promoted into the next higher semester. The issue of degree is liable to be withheld in such cases.

 

General:

 

  1. The academic regulations should be read as a whole for purpose of any interpretation.

 

  1. Disciplinary action for Malpractice / improper conduct in examinations is appended

 

  • Where the words “he”, “him”, “his”, occur in the regulations, they include “she”, “her”, “hers”.

 

  1. In the case of any doubt or ambiguity in the interpretation of the above rules, the decision of the Vice-Chancellor is final.

 

  1. The University may change or amend the academic regulations or syllabi at any time and the changes or amendments shall be made applicable to all the students on roles with effect from the dates notified by the University.

2045 Pharmaceutical Industry || Future Pharma Technologies

2045 Pharmaceutical Industry || Future Pharma Technologies

Hello readers, Let me ask you a question first before we enter the article. What we can expect to see from our pharmaceutical industry in the coming 20 years? Did you ever imagined what can it adapt or inculcate in the future. Do you ever realize the earning capacity of the pharmaceutical market of the globe is 1.2 trillion dollars? At this high profitable and capital stock the Pharmaceutical industry will definitely undergo a huge technological changes in the coming years. Few expect Artificial Intelligence A.I patient empowerment and 3D printed drugs etc to be trending the future.

Every industry paves an adaptation to the changing times with technological advancement and so our Pharmaceutical industry surely embrace new technologies, therapies and innovations.

Artificial Intelligence for Drug Research & Development

Artificial Intelligence for Drug Research & Development will surely bring up a greater focus on ailments, prevention and digital health through speed and savings.
The market of artificial intelligence in global healthcare will reach 31 billion dollars by the end of 2025 as per few studies.
A.I-aided drug design will be a potential too for the new drug discoveries in the very near future. It is really easy to identify the most suitable drugs for diseases through AI as it creates a remarkable perks on the efficiency time and cost.

Patient design

Patient Design includes patients’ input and involvement in drug designs, trials and even decision-making. It is interesting that the FDA created its own patient engagement advisory board to make sure the patients demands heard..
All the Pharmaceutical companies need to follow the FDA in this regard and recently the FDA approved the first artificial pancreas two years after the DIY artificial pancreas was made publicly available.

Robotic integration

2045 Pharmaceutical Industry || Future Pharma Technologies
The greater technological advancement raises the integration of robots in the drug manufacturing processes where they can automate tasks in different tasks.
Robotics, in the form of exoskeletons can take up heavy loads and long hours assisting the manual labors.

Blockchain Technology

Blockchain could bring a radical security measure to the drug distribution chain via a barcode record system that can be tracked from the manufacturer to the end user. This way, medicines
can be tracked in real-time by authorized parties and patients, making it much more difficult for criminal networks to thrive. By being a simple yet secure measure, we will see pharma companies investing more and more into blockchain.

New drug strategies

Pharma companies will focus on newer approaches in drug manufacturing relying on technology to appeal more to providers and payers.

Example:

The “around the pill” strategy is one such New drug strategies.It’s about developing a drug and attaching a digital health technology to it instead
Roche created mySugr app diabetes management app and paired it with Roche’s Accu-Chek Guide glucose meter.
This helps patients to manage their condition by just logging in their blood glucose levels, completing tasks and challenges, users can “tame their diabetes monster”.

Aptitude Reasoning Previous Question Paper Solved Answers 4 pharmacist

Aptitude Reasoning Previous Question Paper Solved Answers 4 pharmacist

Hello readers, Today we present here Aptitude Reasoning Previous Question Paper Solved Answers for all the pharmacy examination whether it is Drug Inspector or any corporate pharmaceutical interview for recruitment of job vacancies.

Aptitude/Reasoning/Subject specialisation previous years solved questions with answers

1. If the following numbers are rewritten by interchanging the digits in ten’s place and hundred’s
place and then arranging them in the descending order. What will be the second digit of the newly
formed fifth number from your right ?
479, 736, 895, 978, 389, 675
(A) 3
(B) 4 (C) 5
(D) 6
Ans : (C)
2. P is 60 m South-East of Q. R is 60 m North-East of Q. Then R is in which direction of P ?
(A) North
(B) North-East
(C) South
(D) South-East
Ans : (A)
Directions’(Q. 3’5) Read the following information for answering the questions that follow’
On a playing ground A, B, C, D and E are standing as described below facing the North.
(i) B is 50 metres to the right of D.
(ii) A is 60 metres to the South of B
(iii) C is 40 metres to the West of D.
(iv) E is 80 metres to the North of A.
3. If a boy walks from C, meets D followed by B, A and then E, how many metres has he walked if
he has travelled the straight distance all through ?
(A) 120
(B) 150
(C) 170
(D) 230
Ans : (D)

Aptitude Reasoning Previous Question Paper Solved Answers 4 pharmacist
4. What is the minimum distance (in metre approximately) between C and E?
(A) 53
(B) 78
(C) 92
(D) 120
Ans : (C)
5. Who is to the South-East of the person who is to the left of D ?
(A) A
(B) B
(C) C
(D) E
Ans : (A)
6. A man was walking in the evening just before the sun set. His wife said that, his shadow fell on
his right. If the wife was walking in the opposite direction of the man, then which direction the
wife was facing ?
(A) North
(B) West
(C) South
(D) East
Ans : (C)

Directions’(Q. 7’11) In each of the following questions choose the set of numbers from the four
alternative sets that is similar to the given set.
7. Given set : (4, 9, 18)
(A) (8, 14, 22)
(B) (10, 15, 25)
(C) (6, 12, 23)
(D) (12, 17, 26)
Ans : (D)
8. Given set : (10, 14, 17)
(A) (4, 11, 14)
(B) (9, 12,
(C) (8, 13, 18)
(D) (6, 9, 12)
Ans : (A)
9. Given set : (7, 27, 55)
(A) (21, 35 , 52)
(B) (18, 42 , 65)
(C) (16, 40 , 72)
(D) (13, 30 , 58)
Ans : (C)
10. Given set : (39, 28, 19)
(A) (84, 67 , 52)
(B) (52, 25 , 17)
(C) (70, 49 , 36)
(D) (65, 45 , 21)
Ans : (A)
11. Given set : (246, 257, 358)
(A) (233, 343, 345)
(B) (273, 365, 367)
(C) (143, 226, 237)
(D) (145, 235, 325)
Ans : (A)

Directions’(Q. 12’16) Each question contains six or seven statements followed by four sets of
combinations of three. Choose the set in which the statements are logically related.
12.
(1) All books are having pages.
(2) All kings are having pages.
(3) All kings are books.
(B) 4, 2, 6
(C) 1, 5, 3
(D) 2, 4, 5
Ans : (B)
Directions’(Q. 17’21) Each of the questions below consists of a question and two statements
numbered (I) and (II). You have to decide whether the data provided in the statements are
sufficient to answer the question. Give answers’
(A) If the data in statement (I) alone are sufficient to answer the question, while the data in
statement (II) alone are not sufficient to answer the question;
(B) If the data in statement (II) alone are sufficient to answer the question, while the data in
statement (I) alone are not sufficient to answer the questions;
(C) If the data even in both statements (I) and (II) together are not sufficient to answer the
question;
(D) If the data in both statement (I) and (II) together are necessary to answer the question.
17. In which direction is Mahatmaji’s statue facing ?
I. The statue is towards the northern end of the city.
II. The statue’s shadow falls towards East at 5 O’clock in the evening.
Ans : (C)
18. What is the total number of pupils in the final year class ?
I. The number of boys in the final year class is twice as much as the number of girls in that class.
II. The sum of the ages of all the pupils in the class is 399 years and their average age is 19
years.
Ans : (B)
19. Who is the tallest among A, B, C and D ?
I. A is taller than C.
II. B is taller than C and D.
Ans : (C)
20. How many Sundays are there in a particular month of a particular year?
I. The month begins on Monday.
II. The month ends on Wednesday.
Ans : (D)
21. What is the total number of pages in this book ?
I. I counted 132 pages from the beginning of this book.
II. My wife counted 138 pages starting from the end of the same book.
Ans : (C)

Directions’(Q. 22’26) In each of the questions given below, there is a statement followed by  three assumptions numbered I, II and III. An assumption is something supposed or taken for granted. You have to consider the statement and assumptions and then decide, which of the
assumption(s) is/are implicit in the statement.

22. Statement : During pre-harvest kharif seasons, the government has decided to release vast quantity of foodgrains from FCI.
Assumptions :I. There may be a shortage of foodgrains in the market during this season.
II. The kharif crop may be able to replenish the stock of FCI.
III. There may be a demand from the farmers to procure kharif crop immediately after harvest.
(A) None is implicit
(B) Only I and II are implicit (C) Only II and III are implicit (D) All are implicit
Ans : (D)
23. Statement : To improve the employment situation in India, there is a need to recast the
present educational system towards implementation of scientific discoveries in daily life.
Assumptions :I. The students after completing such education may be able
to earn their livelihood.
II. This may bring meaning of education in the minds of the youth.
III. The state may earn more revenue as more and more people will engage themselves in self
employment.
(A) Only I and II are implicit
(B) Only III is implicit
(C) Only I and III are implicit
(D) None is implicit
Ans : (A)
24. Statement : To increase profit, the oil exporting countries decided to reduce the production of
crude by 5 million barrels per day. Assumptions :I. The price of crude may increase due to less
production. II. The demand of crude may remain same in future.
III. Other countries may continue buying crude from these countries. (A) All are implicit
(B) Only II and III are implicit (C) Only I and II are implicit (D) None is implicit
Ans : (C)
25. Statement : ’We do not want you to see our product on newspaper, visit our shop to get a full
view.’ ’ an advertisement.
Assumptions :I. People generally decide to purchase any product after seeing the name in the
advertisement.
II. Uncommon appeal may attract the customers. III. People may come to see the product.
(A) All are implicit
(B) None is implicit
(C) Only II and III are implicit
(D) Only I and II are implicit
Ans : (A)
26. Statement : The Reserve Bank of India has directed the banks to refuse fresh loans to major
defaulters.
Assumptions :I. The banks may still give loans to the defaulters.
II. The defaulters may repay the earlier loan to get fresh loan.
III. The banks may recover the bad loans through such harsh measures.
(A) All are implicit
(B) None is implicit
(C) Both II and III are implicit
(D) Both I and II are implicit
Ans : (C)
Directions’(Q. 27’31) In questions given below, statements 1 and 2 are followed by conclusions I
and II. Taking the statements to be right although they may seem at variance with commonly
accepted facts, mark your answers as under’
(A) If only conclusion I follows.
(B) If only conclusion II follows.
(C) If both I and II follows.
(D) Neither I nor II follows.
27. Statements :
1. All hands are machines.
2. All machines are wheels.
Conclusions :I. All wheels are hands.
II. All hands are wheels.
Ans : (B)
28. Statements :
1. Some buds are leaves.
2. Some leaves are red. Conclusions :
I. Some buds are red.
II. Some leaves are not buds.
Ans : (B)
29. Statements :
1. Some stones are shells.
2. All shells are pearls.
Conclusions :
I. Some stones are pearls.
II. All pearls are shells.
Ans : (A)
30. Statements :
1. Brown is red and blue is green.
2. Green is pink and yellow is red. Conclusions :
I. Yellow is brown.
II. Pink is blue.
Ans : (C)